1992年8月至1996年8月我院收治浅表性膀胱癌48例,均行膀胱部分切除。术中常规在肿瘤基部注射噻替哌,其中28例术后兼作BCG膀胱灌注治疗,降低了癌肿复发率,现报告如下。 临床资料 48例病人中男性38例,女性10例;年龄31～75岁。肿瘤生长单个29例,2个以上17例。肿瘤生长部位主要在膀胱三角区及两侧壁,约占80％,余为膀胱顶部、底部、颈口等。肿瘤大小:直径1～3cm为37例,3cm以上11例,手术方式:膀胱部分切除42例,膀胱部分切除术加输尿管移植6例。病理报告检查均为移行上皮癌,Ⅰ级6例,Ⅱ级29例,Ⅲ级3例。 方法:切除肿瘤后用弯长针头于基部周围粘膜下呈放射状注 August 1992 to August 1996 admitted to our hospital 48 cases of superficial bladder cancer, underwent partial resection of the bladder. Intraoperative routine injection of thiotepa at the base of the tumor, of which 28 cases both postoperative BCG bladder irrigation treatment, reducing the recurrence rate of cancer, are as follows. Clinical data 48 patients, 38 males and 10 females; aged 31 to 75 years. Tumor growth in a single 29 cases, more than 2 in 17 cases. Tumor site mainly in the bladder trigone and both sides of the wall, accounting for about 80%, the remaining bladder top, bottom, neck and mouth. Tumor size: diameter of 1 ~ 3cm for 37 cases, 3cm above 11 cases, surgical methods: partial resection of the bladder in 42 cases, partial resection of the bladder plus ureteral transplantation in 6 cases. Pathological reports were examined for transitional epithelial carcinoma, grade Ⅰ in 6 cases, grade Ⅱ in 29 cases, grade Ⅲ in 3 cases. Methods: After removal of the tumor, a long, curved needle was injected radially around the base of the mucosa